Despite the exceptional progress in breast cancer pathogenesis, prognosis, diagnosis, and
treatment strategies, it remains a prominent cause of female mortality worldwide …

Biomarkers play an essential role in the management of patients with invasive breast
cancer. For selecting patients likely to respond to endocrine therapy, both oestrogen …

PURPOSE To update key recommendations of the American Society of Clinical
Oncology/College of American Pathologists estrogen (ER) and progesterone receptor (PgR) …

Purpose.—To update key recommendations of the American Society of Clinical
Oncology/College of American Pathologists estrogen receptor (ER) and progesterone …

Highlights•This ESO-ESMO ABC 5 Clinical Practice Guideline provides key
recommendations for managing advanced breast cancer patients.•It provides updates on …

ABSTRACT The 14th St Gallen International Breast Cancer Conference (2015) reviewed
substantial new evidence on locoregional and systemic therapies for early breast cancer …

Breast cancer (BC) is a heterogeneous disease, encompassing a diverse spectrum of
tumours with varying morphological, biological, and clinical phenotypes. Although tumours …

Assessment of tumor-infiltrating lymphocytes (TILs) is increasingly recognized as an integral
part of the prognostic workflow in triple-negative (TNBC) and HER2-positive breast cancer …

Breast cancer is the leading cause of death among women globally. Approximately 80% of
all breast cancers diagnosed are overexpressed with estrogen receptors (ERs). In this study …

Recent advancements in breast cancer treatment have ushered in a new era of precision
medicine. Novel trials have led to the approval of a growing list of personalized therapies …